Accord Healthcare

Accord Healthcare is a young and dynamic pharmaceutical company, involved in the development, manufacturing and distribution of pharmaceutical products to more than 70 countries globally.
 

DRUG
REACTION
REPORT

report

GROWTH’S IN OUR NATURE

Accord Healthcare is one of the fastest growing generic pharmaceutical companies in Ireland and the UK.

Acquiring Actavis Ireland and the UK in 2017 facilitates Accord’s ambition of becoming a top 5 pan-EMEA generics company by 2020 and a leading player in the industry at European level.

01

TRULY MULTINATIONAL

Accord has one of the most extensive sales, marketing and distribution networks in Europe. Headquartered from UK, Accord now supplies products in close to 65 EMENA markets.

02

A COMPLETE APPROACH

Accord’s vision is to be involved in all aspects of bringing pharmaceuticals to patients. Our activities today encompass the entire pharmaceutical value chain and so create a truly integrated offering.

 

03

EUROPEAN FOCUS

Accord currently has a portfolio comprising nearly 7000 product approvals in Europe. We operate a pan European commercial footprint with direct presence in all major EU markets.

04

News

15-01-2018

Accord Healthcare announces European Commission approval and completion of its purchase of a Basket of products from TEVA

Accord Healthcare is pleased to announce EC approval has been granted for its purchase of European Economic Area (EEA) rights to a basket of 13 products from TEVA.  

11-12-2017

Accord Healthcare – Agile Supply in a Crowded Market

Following a major acquisition of another leading generic pharmaceutical company, Accord Healthcare looks to continue to supply the generic medicine industry while mitigating the risks that come wit